Abstract FTO (fat mass and obesity associated gene) was genetically identified to be associated with body mass index (BMI), presumably through functional regulation of energy homeostasis. However, the cellular and molecular mechanisms by which FTO functions remain largely unknown. Using 3T3-L1 preadipocyte as a model to study the role of FTO in adipogenesis, we demonstrated that FTO is functionally required for 3T3-L1 differentiation. FTO knock-down with siRNA inhibited preadipocyte differentiation, whereas ectopic over-expression of FTO enhanced the process. The demethylase activity of FTO is required for differentiation. Level of N6-methyladenosine (m6A) is decreased in cells over-expressing FTO. In contrast, overexpression of R96Q, a FTO missense mutant lack of demethylase activity, had no effect on cellular m6A level and impeded differentiation. Treatment with Rosiglitazone, a PPARγ agonist, could overcome the differentiation inhibition imposed by R96Q mutant, suggesting the effect of FTO is mediated through PPARγ.

Citation: Zhang M, Zhang Y, Ma J, Guo F, Cao Q, Zhang Y, et al. (2015) The Demethylase Activity of FTO (Fat Mass and Obesity Associated Protein) Is Required for Preadipocyte Differentiation. PLoS ONE 10(7): e0133788. https://doi.org/10.1371/journal.pone.0133788 Editor: Julie A. Chowen, Hosptial Infantil Universitario Niño Jesús, CIBEROBN, SPAIN Received: April 7, 2015; Accepted: June 30, 2015; Published: July 28, 2015 Copyright: © 2015 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Data Availability: The microarray data has been submitted to NBCI Gene Expression Omnibus database and is available to public. The accession number is GSE69313. Funding: The authors have no support or funding to report. Competing interests: The authors have declared that no competing interests exist.

Introduction Since the original publication of association between genetic variation in FTO and body mass index [1–4], considerable efforts have been dedicated to elucidating the molecular mechanism of FTO in modulating energy homeostasis. Studies of genetically engineered mouse models have highlighted the level of complexity in uncovering the role of FTO in regulating body composition and energy metabolism[5]. Global germ line KO of FTO resulted in reduced body weight and growth retardation [6–8]. While most germ line inactivation or over-expression models support a positive correlation between FTO activity and fat mass[7–9], adult onset loss of FTO resulted in increased fat mass and reduced lean mass [10]. In addition, knock-down of FTO activity in a sub-region of hypothalamus only led to mild phenotypes comparing to global inactivation, suggesting FTO exerts function in sites beyond hypothalamus[10]. FTO belongs to the Fe (II) and oxoglutarate-dependent AlkB oxygenase family, and was originally shown to catalyze the oxidative demethylation of 3-methylthymidine (m3T) or 3-methyluracil (m3U) in single strand DNA/RNA [11–14]. In 2011 Jia et al reported that FTO could demethylateN6-methyladenosine (m6A) in RNA, and exhibited much higher activity to m6A versus m3U in vitro[15]. The authors also demonstrated that over-expression of FTO led to a decrease of m6A level in cultured cells, suggesting that m6A is a physiological substrate of FTO. Transcriptome-wide studies with m6A-specificRNA immune-precipitation and next generation sequencing revealed m6A modifications are widespread, dynamically and tissue-specifically regulated [16, 17]. Analysis of m6A mRNA in tissues deficient of FTO led to identification of potential transcripts as the targets of demethylation, and established a link between the demethylase activity and physiological processes regulated by FTO [18]. FTO is ubiquitously expressed, with highest levels in brain and hypothalamus [1, 2, 11]. Although much attention has been devoted to FTO function in brain/hypothalamus [8, 11, 19–24], studies beyond the central nervous system are emerging [25, 26]. Adipose tissue is the primary site for lipid storage, and acts as an endocrine organ regulating energy status via secreting and responding to hormones[27]. Several studies reported the effect of FTO over-expression or deficiency on gene expression changes in adipose tissue [7, 28], and progresses have been made towards uncovering the role of FTO in adipogenesis and energy expenditure [29–31]. In this study, we used murine 3T3-L1 preadipocyte as a model[32] and generated cell lines stably expressing wild-type FTO or a mutant lack of demethylase activity. With these tools and global gene expression profiling, we characterized that the demethylase activity of FTO is required for adipogenesis and discuss the pathways that are possibly involved.

Materials and Methods Cell Culture and Adipocyte Differentiation 3T3-L1 cells were purchased from American Type Culture Collection (ATCC). Cells were cultured in high glucose DMEM (Gibco, cat.11995-065) supplemented with 10% bovine calf serum (Hyclone, cat.SH30118.02), 100 U/ml penicillin and 100 mg/ml streptomycin (Gibco, cat.15140-122) in a 5% CO 2 humidified atmosphere. For 3T3-L1 differentiation, post-confluent preadipocytes were incubated with a cocktail of insulin (1 μg/ml, Sigma, cat.I5500), dexamethasone (1 μM, Sigma, cat.D4902), and 3-isobutyl-1-methylxanthine (0.5 μM, Sigma, cat.I7018) in DMEM supplemented with 10% fetal bovine serum (Hyclone) for 48 hours, followed by culture with DMEM, 10% fetal bovine serum and 1 μg/ml insulin for another 48 hours. The media were then removed and replaced with DMEM plus 10% fetal bovine serum until collection for differentiation assessment. For PPARγ pathway studies, rosiglitazone (10 μM, Sigma, cat.R2408) was added to the media at day 0 of induction and throughout the differentiation process. Oil Red-O (Sigma, cat.O0625) staining was performed on day 6 of differentiation following manufacturer’s instruction. In brief, cells were washed twice with PBS and fixed with 10% formalin in PBS for 15 min. After two washes with PBS, cells were stained for at least 1 hour in freshly diluted Oil Red-O solution (stock solution: 0.5% Oil Red-O in isopropanol; for dilution, water:stock solution is 4:6). The staining solution was then removed and cells were washed 3 times with PBS before imaging. To quantify lipid staining, Oil Red-O was extracted by adding 100% isopropanol after imaging, and the absorbance of the extract was measured at 540 nm. FTO Knockdown with siRNAs All siRNAs were purchased from Invitrogen (siFTO-1:UUAAGGUCCACUUCAUCAUCGCAGG, siFTO-2:CAGGCACCUUGGAUUAUAUTT). Cells were plated at 3x105 per well in 6-well plates, and grown for 24 hours in normal growth media. For knock-down experiments, cells were rinsed with Opti-MEM (Invitrogen, cat.31985-062) and incubated with 100 nM siRNA and Lipofectamine2000 (Invitrogen, cat.13778075) for another 24 hours. The transfection media were then replaced with DMEM supplemented with fetal bovine serum, and cells were ready for subsequent differentiation induction. RNA Isolation and RT-qPCR Total cellular RNA was isolated from 3T3-L1 cells using RNeasy Protect Mini Kit (Qiagen, cat.74104). First-strand cDNA synthesis was performed using oligodT-primers with SuperScript III reverse transcriptase (Invitrogen, cat.18080-044). The expression level of each gene was determined with ABI 7500HT Sequence Detection System (Applied Biosystems). Reactions were performed in triplicates with 12.5 μl of Power SYBR Green Master Mix, 300 nM primers, 20 ng of cDNA template or control/nuclease-free water in a final volume of 25 μl. The RT-qPCR reaction consisted of an initial denaturation for 10 min at 95°C, followed by 40 cycles of 95°C for 15 sec, 60°C for 60 sec. Threshold cycle (Ct) values were calculated using ABI SDS 3000 software (Applied Biosystems). All the gene expression data during 3T3-L1 differentiation were normalized using Ywhaz. Primer sequences: Fto:TTCATGCTGGATGACCTCAATG/GCCAACTGACAGCGTTCTAAG Ywhaz:GAAAAGTCTTGATCCCCAATGC/TGTGACTGTCCCAATTCCTT Actb: GCTCGTCGACAACGGCTC/ CAAACATGATCTGGGTCATCTTCTC Cd36:GATGTGGAACCCATAACTGGATTCAC/GGTCCCAGTCTCATTTAGCCACAGTA aP-2: ACATACAGGGTCTGGTG/CAGCACTCACCCACTTCTTTCAT Plin1: TGCTGGATGGAGACCTC/ACCGGCTCCATGCTCCA Adipoq:ATGCCGAAGATGACGTTACTACA/CCTGCACAAGTTCCCTTGGG Fabp5:TGAAAGAGCTAGGAGTAGGACTG/CTCTCGGTTTTGACCGTGATG Pparg:TCGCTGATGCACTGCCTATG/GAGAGGTCCACAGAGCTGATT FTO mutant constructs and cell lines The cDNA of wild-type FTO was amplified by PCR from FTO expressing plasmid pcDNA3.1-N-6His-3myc-FTO-1-505 [14]. Primers bearing Hind III and Xho I sites were used to generate PCR fragments which were subcloned into pcDNA3.1 mammalian expression vectors (Invitrogen). The R96Q mutant of FTO was described previously [14].The cDNA of R96Q was amplified by PCR and cloned into pcDNA3.1 mammalian expression vectors. 3T3-L1 cells were plated at 3x105 per well in six-well plates and transfected with constructs using X-tremeGENE HP DNA(Roche,cat.6366236001) following manufacturer’s instruction. Transfection media were removed after 24 hours and cells were cultured in normal growing media for 48 hours. Cells were then passed 1:10 into 10 cm dishes and grown in selective media with G418 (600 μg/ml, Sigma, cat.A1720) for 21 days when single colonies were picked from each culture. Western-blot analysis Cells were lysed in RIPA buffer with a cocktail of protease inhibitors (Sigma, cat.P8340). 20 μg of protein extracts were separated by SDS-PAGE and transferred to PVDF membranes (Millipore, cat.GVWP2932A). Membranes were blocked with 5% nonfat milk, followed by overnight incubation with primary antibodies against FTO (1:500, Abcam, cat.ab92821), β-actin (1:1000, Cell Signaling Technology, cat.#3700), or Myc (1:500, Abcam, cat.ab9106). Detection was made with HRP conjugated secondary antibody (1:5000, Santa Cruz) and enhanced with chemo-luminescence detection system (Millipore, cat.WBKLSO100). Immunofluorescent Cell Staining Cells growing on coverslips were fixed with 4% paraformaldehyde, permeabilized with 0.01% Triton X-100 (Sigma,cat.9002-93-1), blocked with PBST-0.5% BSA, and incubated sequentially with anti-FTO monoclonal antibody (1:100; Abcam) and FITC-conjugated secondary antibody (1:2000, ZSGB-BIO, cat.ZF-0312). All cells were counterstained with hoechst33342 and mounted in anti-quenching medium (Solarbio, cat.S2100). Imaging analysis was carried out with Nikon A1Rsi confocal microscope. Analysis ofm6A levels in mRNA using dot blot Total RNAs were isolated from cells 24hr after adipogenic differentiation with TRIZOL reagent (Invitrogen, cat.15596-018). Cellular mRNAs were isolated with Poly(A) Purist Kit (Ambion, cat.AM1916), followed by rRNA removal using RiboMinus Transcriptom Isolation Kit (Invitrogen, cat.K1550-01). The concentration and quality of mRNA were determined by NanoDrop (Thermo) and Agilent 2100 bioanalyzer. Purified mRNA was denatured at 95°C for 5 min and then chilled on ice. Two fold serial dilutions were spotted onto Amersham Hybond-N+ membranes (GE Healthcare, cat.RPN303B). After crosslinking at 80°C for 2 hours, the membranes were blocked with 5% nonfat milk in TBST for 1 hour, and incubated with rabbit anti-m6A antibody (1:2000, SySy, cat.202003) overnight at 4°C. Membranes were then incubated with peroxidase-conjugated AffiniPure goat anti-rabbit IgG (H+L) for 1 hour at room temperature, and visualized by Immobilion western Chemoluminescent HRP Substrate (Millipore,cat.WBKL S0050). The intensity of each spot was quantified using ImageJ software (NIH, USA). Gene expression profiling Gene expression profiling was performed with AffymetrixGeneChip Mouse Gene 1.0 ST arrays. After scanning, CEL files were processed at gene level using RMA algorithm of the Affymetrix Expression Console Software 1.1. Probesets without RefSeq annotations were removed from further analysis. Differentially regulated genes were identified using the univariate test in BRB-ArrayTools with a P value of 0.01 as the significance threshold[33]. Pathway enrichment analysis was applied to significantly regulated genes using the Database for Annotation, Visualization and Integrated Discovery (DAVID)[34]. Significantly enriched pathways were identified using a P value of 0.05 as the threshold. The microarray data have been submitted to NCBI GEO database, accession number GSE69313.

Discussion In this report, we used mouse 3T3-L1 preadipocyte as a model to study the function of FTO during adipogenesis. FTO is expressed in preadipocyte, and its mRNA level did not show significant changes up to 6 days after differentiation induction. Knock-down of FTO expression with siRNAs in preadipocyte resulted in a decrease of differentiation into mature adipocytes. To confirm the observation with siRNA knock-down, we generated two lines of 3T3-L1 cells stably expressing wild-type FTO, and a FTO mutant (R96Q) lack of demethylase activity. Consistent with the siRNA knock-down experiments, over-expression of ectopic FTO enhanced differentiation, whereas the R96Q mutant failed to do so, and displayed a dominant negative effect. These observations suggest that the demethylase activity of FTO is required during adipogenesis. We further demonstrated that the effect of FTO on differentiation is mediated through PPARγ, a master regulator of adipogenesis. Rosiglitazone, a PPARγ agonist could partially overcome the inhibition effect observed in R96Q expressing cells. Recent studies suggest m6A as the cellular substrate of FTO [15]. Although the presence of m6A modifications in RNA was discovered decades ago [45–53], its physiological role remains largely unknown. Transcriptome-wide studies indicate m6A modifications are common, highly conserved between mouse and human, and dynamically regulated [16, 17]. In this report, we demonstrated that over-expressing of FTO led to decrease of m6A in 3T3-L1 preadipocytes, accompanied by an increase in differentiation level upon adipogenic induction. In contrast, cells expressing R96Q mutant has no effect on m6A level. Interestingly, the R96Q mutant displayed a dominant negative effect, possibly through competing for substrate binding with endogenous FTO. Two research articles were published very recently highlighting one molecular mechanism through which FTO regulated adipogenesis [29, 30]. Runt related transcription factor 1 (RUNX1T1) was previously shown to impact adipogenesis through C/EBPβ [54]. With the application of RNA-seq and m6A-seq technology, Zhao et al found that FTO controls the exon splicing of RUNX1T1 by regulating m6A levels around splice sites, which led to two isoforms of the protein: the long and the short forms. FTO increases the short form of RUNX1T1 and thus enhances adipocyte differentiation [29]. This observation was also supported in mouse embryonic fibroblasts (MEFs) induced to differentiation into adipocytes [30]. Furthermore, the latter publication demonstrated that FTO exerts its effect by regulating events early in adipogenesis, during the process of mitotic clonal expansion. In a study published in 2013, Tews et al reported that FTO was involved in the white adipose tissue browning, which highlighted the possible role of FTO in regulating energy expenditure [31]. However, knock-down of FTO in human preadipocyte SGBS did not demonstrate an effect on differentiation rate. Our observation that Rosiglitazone could restore differentiation suppression is consistent with the discovery that FTO is upstream of PPARγ, and also explained the discrepancy observed between mouse and human adipocytes, since SGBS was cultured in the presence of rosiglitazone, which probably led to overcoming the differentiation suppression imposed by FTO deficiency. Using microarray, we explored the transcriptional changes induced by FTO knock-down during 3T3-L1 differentiation. Six hours after induction, an up-regulation of the Wnt pathway was detected. Activation of canonical Wnt signaling by Wnt10b was previously shown to block adipogenesis, possibly through interaction with PPARγ [37, 38, 55]. We detected a mild increase of Wnt10b transcript at 6 hr post induction. At 72 hr, a decrease of PPARγ responsive genes was observed. One possible mechanism of FTO regulating 3T3-L1 differentiation might be via increasing Wnt signaling, and thus suppress PPARγ activity. It would be important for mechanistic understanding to investigate the effect of activation of Wnt pathway on adipogenesis upon ectopic expression of FTO. Another interesting observation from the microarray data is that many of the transcripts regulated by FTO knock-down contains m6A sites (450 out of 970), again highlighting the important role of demethylase activity of FTO. The critical role of demethylase activity has been highlighted in various tissues/cell lines besides adipose/adipocytes. Recently it was demonstrated that FTO could act as link between amino acid sensing and mammalian target of rapamycin (mTOR) signaling, and thus possibly influence body composition through playing a role in cellular nutrient sensing [56]. A demethylase mutant of FTO, R316Q, however, was ineffective in coupling amino acids deprivation to mTOR signaling [56]. In another study, FTO expression is correlated with reduced level of m6A in ghrelin mRNA, and postulated to regulate food intake through regulating ghrelin level [57].The more recent studies in adipocytes as well as adipose tissues in FTO-/- or FTO over-expressing mice further demonstrated the critical roles played by the demethylase activity of FTO. Interestingly, over-expression of FTO in MEF cells did not show an impact on m6A level [28], suggesting the effect of FTO-dependent demethylation could be tissue-specific and/or temporally regulated. The establishment of 3T3-L1 lines stably expressing FTO and a demethylase mutant will allow further investigation of the demethylation targets of FTO during adipogenesis. In conclusion, we demonstrated that FTO plays an important role in preadipocyte differentiation, and demethylation modification of m6A is required during this process. The effect of FTO is mediated, at least partially through PPARγ. Our study set the basis for further investigation into the molecular mechanisms underlying the involvement of FTO during adipogenesis.

Author Contributions Conceived and designed the experiments: JC WZ RZ. Performed the experiments: MZ YZ QC YZ FG BZ. Analyzed the data: JM. Wrote the paper: RZ WZ.